Kenya has received a substantial financial injection of Sh43 billion from the US President’s Emergency Plan for Aids Relief (Pepfar) to bolster its fight against HIV in 2025. This move comes as a lifeline for hundreds of thousands of Kenyans battling HIV, ensuring access to crucial antiretroviral drugs and essential healthcare services.
Nelson Otwoma, head of Nephak, expressed gratitude for the renewed funding, stating, “It’s a welcome move because there was a lot of anxiety. Hundreds of thousands of Kenyans with HIV rely on Pepfar funding to stay alive and in good health.”
The Pepfar extension, part of the 2024 US spending bill, underscores the critical role foreign donors play in supporting Kenya’s HIV response. With over 1.4 million people living with HIV in Kenya, sustained funding is paramount to ensuring continued access to treatment and care.
Dr. Mutinda Mutuku, a health economist, emphasized the importance of transitioning towards greater domestic financing for healthcare, citing the need for long-term sustainability. As Kenya progresses towards self-reliance in funding its health programs, strategic planning and increased government contributions will be key to safeguarding public health initiatives.
The Pepfar-funded initiative signifies a pivotal step in Kenya’s journey towards self-sufficiency in healthcare financing, paving the way for a more resilient and sustainable healthcare system.
